Somatostatin, cortistatin and their receptors in tumours

Molecular and Cellular Endocrinology

Volumn 286, Issue 1-2, 2008, Pages 219-229

  Volante, M ^a   Rosas, R ^a   Allia E ^a   Granata, R ^b   Baragli, A ^a   Muccioli, G ^a   Papotti, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cortistatin; Human cancer; MrgX2 receptor; Neuroendocrine; Somatostatin; Somatostatin receptor

Indexed keywords

CORTISTATIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR 1; HORMONE RECEPTOR; NEUROPEPTIDE RECEPTOR; PASIREOTIDE; PROTEIN MRGX2; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

CELL PROLIFERATION; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; DRUG INHIBITION; DRUG TARGETING; HUMAN; NEUROENDOCRINE TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TUMOR GROWTH;

EID: 43749098064     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.12.002     Document Type: Review

References (152)

1. E. Allia E. Tarabra M. Volante M. Cerrato E. Ghigo G. Muccioli M. Papotti Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours J. Pathol. 207 2005 336 345
2. E. Ballare L. Persani A.G. Lania M. Filopanti E. Giammona S. Corbetta S. Mantovani M. Arosio P. Beck-Peccoz G. Faglia A. Spada Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment J. Clin. Endocrinol. Metab. 86 2001 3809 3814
3. D.L. Batista X. Zhang R. Gejman P.J. Ansell Y. Zhou S.A. Johnson B. Swearingen E.T. Hedley-Whyte C.A. Stratakis A. Klibanski The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in uman corticotroph pituitary adenomas J. Clin. Endocrinol. Metab. 91 2006 4482 4488
4. N. Berenger J.L. Moretti C. Boaziz N. Vigneron J.F. Morere J.L. Breau Somatostatin receptor imaging in small cell lung cancer Eur. J. Cancer 32 1996 1429 1431
5. S.R. Bloom C.H. Mortimer M.O. Thorner G.M. Besser R. Hall A. Gomez-Pan V.M. Roy R.C. Russell D.H. Coy A.J. Kastin A.V. Schally Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone Lancet 2 1974 1106 1109
6. S.R. Bloom D.N. Ralphs G.M. Besser R. Hall D.H. Coy A.J. Kastin A.V. Schally Proceedings: effect of somatostatin on motilin levels and gastric emptying Gut 16 1975 834 1834
7. C. Bousquet E. Puente L. Buscail N. Vaysse C. Susini Antiproliferative effect of somatostatin and analogs Chemotherapy 47 2001 30 39
8. F. Broglio E. Arvat A. Benso C. Gottero F. Prodam S. Grottoli M. Papotti G. Muccioli A.J. Van der Lely R. Deghenghi E. Ghigo Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans J. Clin. Endocrinol. Metab. 87 2002 3783 3790
9. G. Butturini R. Bettini E. Missiaglia W. Mantovani I. Dalai P. Capelli M. Ferdeghini P. Pederzoli A. Scarpa M. Falconi Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma Endocr. Relat. Cancer 13 2006 1213 1221
10. P. Cassoni G. Muccioli T. Marrocco M. Volante E. Allia E. Ghigo R. Deghenghi M. Papotti Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin J. Endocrinol. Invest. 25 2002 362 368
11. P. Cassoni E. Allia T. Marrocco C. Ghe E. Ghigo G. Muccioli M. Papotti Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumours and in vitro effect on the H345 small cell carcinoma cell line J. Endocrinol. Invest. 29 2006 781 790
12. R. Cescato S. Schulz B. Waser V. Eltschinger J.E. Rivier H.J. Wester M. Culler M. Ginj Q. Liu A. Schonbrunn J.C. Reubi Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists J. Nucl. Med. 47 2006 502 511
13. V.A. Dalm P.M. van Hagen P.M. van Koetsveld S. Achilefu A.B. Houtsmuller D.H. Pols A.J. van der Lely S.W. Lamberts L.J. Hofland Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells Am. J. Physiol. Endocrinol. Metab. 285 2003 E344 E353
14. V.A. Dalm P.M. Van Hagen P.M. Van Koetsveld A.W. Langerak A.J. Van Der Lely S.W. Lamberts L.J. Hofland Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system J. Clin. Endocrinol. Metab. 88 2003 270 276
15. V.A. Dalm P.M. Van Hagen R.R. de Krijger J.M. Kros P.M. Van Koetsveld A.J. Van Der Lely S.W. Lamberts L.J. Hofland Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues Clin. Endocrinol. 60 2004 625 629
16. Y. Dayal K. Oberg A. Perren P. Komminoth Somatostatinoma R.A. De Lellis R.V. Lloyd Ph.U. Heitz C. Eng WHO Classification of Tumours Pathology and Genetics. Tumours of the Endocrine Organs 2004 IARC Press Lyon pp. 189–190
17. W.W De Herder S.W. Lamberts Somatostatin and somatostatin analogs: diagnostic and therapeutic uses Curr. Opin. Oncol. 14 2002 53 57
18. M. De Jong W.A. Breeman B.F. Bernard W.H. Bakker M. Schaar A. van Gameren J.E. Bugaj J. Erion M. Schmidt A. Srinivasan E.P. Krenning [177Lu-DOTA(0) Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy Int. J. Cancer 92 2001 628 633
19. L. De Lecea J.P. Castano Cortistatin: not just another somatostatin analog Nat. Clin. Pract. Endocrinol. Metab. 2 2006 356 357
20. L. De Lecea J.R. Criado O. Prospero-Garcia K.M. Gautvik P. Schweitzer P.E. Danielson C.L. Dunlop G.R. Siggins S.J. Henriksen J.G. Sutcliffe A cortical neuropeptide with neuronal depressant and sleep-modulating properties Nature 381 1996 242 245
21. L. De Lecea P. Ruiz-Lozano P.E. Danielson J. Peelle-Kirley P.E. Foye W.N. Frankel J.G. Sutcliffe Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin Genomics 42 1997 499 506
22. R. Deghenghi M. Papotti E. Ghigo G. Muccioli Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptor of human pituitary gland J. Endocrinol. Invest. 24 2001 RC1 RC3
23. R. Deghenghi F. Broglio M. Papotti G. Muccioli E. Ghigo Targeting the ghrelin receptor orally active GHS and cortistatin analogs Endocrine 22 2003 13 18
24. R.A. DeLellis R.V. Lloyd Ph.U. Heitz C. Eng World Health Organisation Classification of Tumors. Pathology and Genetcis: Tumors of Endocrine Organs 2004 IARC Press Lyon pp. 185–190
25. D. Dimitroulopoulos D. Xinopoulos K. Tsamakidis A. Zisimopoulos E. Andriotis S. Markidou D. Panagiotakos C. Chrysohoou A. Bazinis E. Paraskevas The role of sandostatin LAR in treating patients with advanced hepatocellular cancer Hepatogastroenterology 49 2002 1245 1250
26. N. Dizeyi L. Konrad A. Bjartell H. Wu V. Gadaleanu J. Hansson L. Helboe P.A. Abrahamsson Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines Urol. Oncol. 7 2002 91 98
27. A. Dutour U. Kumar R. Panetta L. Ouafik F. Fina R. Sasi Y.C. Patel Expression of somatostatin receptor subtypes in human brain tumours Int. J. Cancer 76 1998 620 627
28. J. Epelbaum Somatostatin in the central nervous system: physiology and pathological modifications Prog. Neurobiol. 27 1986 63 100
29. M. Falconi U. Plockinger D.J. Kwekkeboom R. Manfredi M. Korner L. Kvols U.F. Pape J. Ricke P.E. Goretzki S. Wildi T. Steinmuller K. Oberg J.Y. Scoazec Frascati Consensus Conference; European Neuroendocrine tumour society. Well-differentiated pancreatic non-functioning tumours/carcinoma Neuroendocrinology 84 2006 196 211
30. M. Fedele I. De Martino R. Pivonello A. Ciarmiello M.L. Del Basso De Caro R. Visone D. Calmieri G.M. Pierantoni C. Arra H.A. Schmid L. Hofland G. Lombardi A. Colao A. Fusco SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas Clin. Cancer Res. 13 2007 2738 2744
31. D. Ferone L.J. Hofland A. Colao S.W. Lamberts P.M. van Hagen Neuroendocrine aspects of immunolymphoproliferative diseases Ann. Oncol. 12 2001 S125 S130
32. D. Ferone D.J. Kwekkeboom R. Pivonello A.D. Bogers A. Colao S.W. Lamberts P.M. van Hagen L.J. Hofland In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features J. Endocrinol. Invest. 24 2001 522 528
33. D. Ferone M. Arvigo C. Semino P. Jaquet A. Saveanu J.E. Taylor J.P. Moreau M.D. Culler M. Albertelli F. Minuto A. Barreca Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation Am. J. Physiol. Endocrinol. Metab. 289 2005 E1044 E1050
34. D. Ferone M. Boschetti E. Resmini M. Giusti V. Albanese U. Goglia M. Albertelli L. Vera F. Bianchi F. Minuto Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system Ann. N. Y. Acad. Sci. 1069 2006 129 144
35. J.W. Friedberg Van den Abbeel A.D. e K. Kehoe S. Singer C.D. Fletcher G.D. Demetri Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma Cancer 86 1999 1621 1627
36. S. Fukusumi C. Kitada S. Takekawa H. Kizawa J. Sakamoto M. Miyamoto S. Hinuma K. Kitano M. Fujino Identification and characterization of a novel human cortistatin-like peptide Biochem. Biophys. Res. Commun. 232 1997 157 163
37. E. Gonzalez-Rey N. Varela A.F. Sheibanie A. Chorny D. Ganea M. Delgado Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease Proc. Natl. Acad. Sci. U.S.A. 103 2006 4228 4233
38. E. Gonzalez-Rey A. Chorny G. Robledo M. Delgado Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia J. Exp. Med. 203 2006 563 571
39. E. Gonzalez-Rey A. Chorny R.G. Del Moral N. Varela M. Delgado Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses Ann. Rheum. Dis. 66 2007 582 588
40. C. Gottero F. Prodam S. Destefanis A. Benso C. Gauna E. Me L. Filtri F. Riganti A.J. Van Der Lely E. Ghigo F. Broglio Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans Growth Horm. IGF Res. 14 2004 382 387
41. A. Grimberg Somatostatin and cancer: applying endocrinology to oncology Cancer Biol. Ther. 3 2004 731 733
42. S. Grottoli V. Gasco F. Broglio R. Baldelli F. Ragazzoni F. Gallenca A. Mainolfi F. Prodam G. Muccioli E. Ghigo Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma J. Clin. Endocrinol. Metab. 91 2006 1595 1599
43. J. Guillermet N. Saint-Laurent P. Rochaix O. Cuvillier T. Levade A.V. Schally L. Pradayrol L. Buscail C. Susini C. Bousquet Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis Proc. Natl. Acad. Sci. U.S.A. 100 2003 155 160
44. G.H. Hall L.W. Turnbull I. Richmond L. Helboe S.L. Atkin Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours Br. J. Cancer 87 2002 86 90
45. A. Hamy M.F. Heymann J. Bodic J. Visset J. Le Borgne J.C. Leneel M.F. Le Bodic Duodenal somatostatinoma anatomic/clinical study of 12 operated cases Ann. Chir. 126 2001 221 226
46. L.M. Haslinghuis E.P. Krenning W.W. De Herder A.E. Reijs D.J. Kwekkeboom Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer J. Endocrinol. Invest. 24 2001 415 422
47. L.J. Hofland S.W. Lamberts The pathophysiological consequences of somatostatin receptor internalization and resistance Endocr. Rev. 24 2003 28 47
48. L.J. Hofland Q. Liu P.M. Van Koetsveld J. Zuijderwijk F. Van Der Ham R.R. de Krijger A. Schonbrunn S.W. Lamberts Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumours J. Clin. Endocrinol. Metab. 84 1999 775 780
49. L.J. Hofland J. van der Hoek R. Feelders A.J. van der Lely W. de Herder S.W. Lamberts Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects J. Endocrinol. Invest. 28S 2005 36 42
50. D. Hoyer G.I. Bell M. Berelowitz J. Epelbaum W. Feniuk P.P. Humphrey A.M. O’Carroll Y.C. Patel A. Schonbrunn J.E. Taylor Classification and nomenclature of somatostatin receptors Trends Pharmacol. Sci. 16 1995 86 88
51. C. Hu C. Yi Z. Hao S. Cao H. Li X. Shao J. Zhang T. Qiao D. Fan The effect of somatostatin and sst3 on proliferation and apoptosis of gastric cancer cells Cancer Biol. Ther. 3 2004 726 730
52. N. Hukovic R. Panetta U. Kumar Y.C. Patel Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hsst1-5): subtype selective internalization or upregulation Endocrinology 137 1996 4046 4049
53. E.T. Janson A. Gobl K.M. Kalkner K. Oberg A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients Cancer Res. 56 1996 2561 2565
54. E.T. Janson M. Stridsberg A. Gobl J.E. Westlin K. Oberg Determination of somatostatin receptor subtype 2 in carcinoid tumours by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies Cancer Res. 58 1998 2375 2378
55. P. Jaquet G. Gunz A. Saveanu H. Dufour J. Taylor J. Dong S. Kim J.P. Moreau A. Enjalbert M.D. Culler Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy Eur. J. Endocrinol. 153 2005 135 141
56. G.A. Kaltsas D. Papadogias P. Makras A.B. Grossman Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues Endocr. Relat. Cancer 12 2005 683 699
57. M. Kamohara A. Matsuo J. Takasaki M. Kohda M. Matsumoto S. Matsumoto T. Soga H. Hiyama M. Kobori M. Katou Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides Biochem. Biophys. Res. Commun. 330 2005 1146 1152
58. N. Kimura M. Pilichowska F. Date I. Kimura M. Schindler Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumours Clin. Cancer Res. 5 1999 3483 3487
59. P. Kogner P. Borgstrom P. Bjellerup F.H. Schilling E. Refai C. Jonsson C. Dominici E. Wassberg H. Bihl H. Jacobsson E. Theodorsson M. Hassan Somatostatin in neuroblastoma and ganglioneuroma Eur. J. Cancer 33 1997 2084 2089
60. J.W. Koper L.J. Hofland P.M. van Koetsveld F. den Holder S.W. Lamberts Desensitization and resensitization of rat pituitary tumour cells in long-term culture to the effects of the somatostatin analogue SMS 201-995 on cell growth and prolactin secretion Cancer Res. 50 1990 6238 6242
61. M. Korner V. Eltschinger B. Waser A. Schonbrunn J.C. Reubi Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: lessons from the comparison of anti-sst2A antibodies with somatostatin receptor autoradiography Am. J. Surg. Pathol. 29 2005 1642 1651
62. H.J. Kreienkamp Molecular biology of the receptors for somatostatin and cortistatin Results Probl. Cell. Differ. 26 1999 215 237
63. L. Krulich A.P. Dhariwal S.M. McCann L. Krulich A.P. Dhariwal S.M. McCann Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro Endocrinology 83 1968 783 790
64. A. Kubota Y. Yamada S. Kagimoto A. Shimatsu M. Imamura K. Tsuda H. Imura S. Seino Y. Seino Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumours J. Clin. Invest. 93 1994 1321 1325
65. H. Kulaksiz R. Eissele D. Rossler S. Schulz V. Hollt Y. Cetin R. Arnold Identification of somatostatin receptor subtypes 1 2A 3 and 5 in neuroendocrine tumours with subtype specific antibodies Gut 50 2002 52 60
66. D.J. Kwekkeboom J.C. Reubi S.W. Lamberts H.A. Bruining A.H. Mulder H.Y. Oei E.P. Krenning In vivo somatostatin receptor imaging in medullary thyroid carcinoma J. Clin. Endocrinol. Metab. 76 1993 1413 1417
67. S.W. Lamberts The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumours Endocr. Rev. 9 1988 417 436
68. S.W. Lamberts J.C. Reubi P. Uiterlinden J. Zuiderwijk P. van den Werff P. van Hal Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumour 7315a Endocrinology 118 1986 2188 2194
69. S.W. Lamberts E.P. Krenning J.C. Reubi The role of somatostatin and its analogs in the diagnosis and treatment of tumours Endocr. Rev. 12 1991 450 482
70. S.W. Lamberts A.J. van der Lely W.W. de Herder L.J. Hofland Octreotide N. Engl. J. Med. 334 1996 246 254
71. S. Lastoria E. Vergara G. Palmieri W. Acampa P. Varrella C. Caraco R.A. Bianco P. Muto M. Salvatore In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy J. Nucl. Med. 39 1998 634 639
72. S.A. Laws A.C. Gough A.A. Evans M.A. Bains J.N. Primrose Somatostatin receptor subtype mRNA expression in human colorectal cancer and normal colonic mucosae Br. J. Cancer 75 1997 360 366
73. I. Lewis W. Bauer R. Albert N. Chandramouli J. Pless G. Weckbecker C. Bruns A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential J. Med. Chem. 46 2003 2334 2344
74. Q. Liu R. Cescato D.A. Dewi J. Rivier J.C. Reubi A. Schonbrunn Receptor signaling and endocytosis are differentially regulated by somatostatin analogs Mol. Pharmacol. 68 2005 90 101
75. M.J. Low The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders Best Pract. Res. Clin. Endocrinol. Metab. 18 2004 607 622
76. P.J. Lugtenburg E.P. Krenning R. Valkema H.Y. Oei S.W. Lamberts M.J. Eijkemans W.L. van Putten B. Lowenberg Somatostatin receptor scintigraphy useful in stage I–II Hodgkin's disease: more extended disease identified Br. J. Haematol. 112 2001 936 944
77. S.S. Lum W.S. Fletcher M.S. O’Dorisio R.W. Nance R.F. Pommier M. Caprara Distribution and functional significance of somatostatin receptors in malignant melanoma World J. Surg. 25 2001 407 412
78. R.M. Luque J.R. Peinado F. Gracia-Navarro F. Broglio E. Ghigo R.D. Kineman M.M. Malagon J.P. Castano Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes J. Mol. Endocrinol. 36 2006 547 556
79. N. Mahy M. Woolkalis D. Manning T. Reisine Characteristics of somatostatin desensitization in the pituitary tumour cell line AtT-20 J. Pharmacol. Exp. Ther. 247 1988 390 396
80. J.D. Mao P. Wu X.H. Xia J.Q. Hu W.B. Huang G.Q. Xu Correlation between expression of gastrin, somatostatin and cell apoptosis regulation gene bcl-2/bax in large intestine carcinoma World J. Gastroenterol. 11 2005 721 725
81. E. Mato X. Matias-Guiu A. Chico S.M. Webb R. Cabezas L. Berna A. De Leiva Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma J. Clin. Endocrinol. Metab. 83 1998 2417 2420
82. C. Mawrin S. Schulz A. Hellwig-Patyk E. Kirches A. Roessner U. Lendeckel R. Firsching C.K. Vorwerk G. Keilhoff K. Dietzmann K. Grimm G. Lindberg D.H. Gutmann B.W. Scheithauer A. Perry Expression and function of somatostatin receptors in peripheral nerve sheath tumours J. Neuropathol. Exp. Neurol. 64 2005 1080 1088
83. B. Moayedoddin F. Booya R.A. Wermers R.V. Lloyd J. Rubin G.B. Thompson V. Fatourechi Spectrum of malignant somatostatin-producing neuroendocrine tumours Endocr. Pract. 12 2006 394 400
84. G. Notas G. Kolios N. Mastrodimou M. Kampa A. Visilaki C. Xidakis E. Castanas K. Thermos E. Kouroumalis Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors J. Hepatol. 40 2004 792 798
85. K. Oberg Carcinoid tumours: molecular genetics, tumour biology, and update of diagnosis and treatment Curr. Opin. Oncol. 14 2002 38 45
86. K. Oberg L. Kvols M. Caplin G. Delle Fave W. de Herder G. Rindi P. Ruszniewski E.A. Woltering B. Wiedenmann Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumours of the gastroenteropancreatic system Ann. Oncol. 15 2004 966 973
87. N. Ohike A. Jurgensen M. Pipeleers-Marichal G. Kloppel Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells Virchows Arch. 442 2003 258 265
88. D. O’Toole A. Saveanu A. Couvelard G. Gunz A. Enjalbert P. Jaquet P. Ruszniewski A. Barlier The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies Eur. J. Endocrinol. 155 2006 849 857
89. F. Pacini F. Basolo R. Elisei L. Fugazzola A. Cola A. Pinchera Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens Am. J. Clin. Pathol. 95 1991 300 308
90. M. Papotti L. Macri G. Bussolati J.C. Reubi Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas Int. J. Cancer 43 1989 365 369
91. M. Papotti S. Croce L. Macri A. Funaro C. Pecchioni M. Schindler G. Bussolati Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumours of the lung Diagn. Mol. Pathol. 9 2000 47 57
92. M. Papotti S. Croce M. Bello M. Bongiovanni E. Allia M. Schindler G. Bussolati Expression of somatostatin receptor types 23 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy Virchows Arch. 439 2001 787 797
93. M. Papotti U. Kumar M. Volante C. Pecchioni Y.C. Patel Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid Clin. Endocrinol. (Oxf.) 54 2001 641 649
94. M. Papotti P. Cassoni M. Volante R. Deghenghi G. Muccioli E. Ghigo Ghrelin-producing endocrine tumours of the stomach and intestine J. Clin. Endocrinol. Metab. 86 2001 5052 5059
95. M. Papotti M. Bongiovanni M. Volante E. Allia S. Landolfi L. Helboe M. Schindler S.L. Cole G. Bussolati Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumours. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis Virchows Arch. 440 2002 461 475
96. M. Papotti E. Tarabra E. Allia F. Bozzalla Cassione F. Broglio R. Deghenghi E. Ghigo G. Muccioli Presence of cortistatin in the human pancreas J. Endocrinol. Invest. 26 2003 RC15 RC18
97. Y.C. Patel Molecular pharmacology of somatostatin receptor subtypes J. Endocrinol. Invest. 20 1997 348 367
98. Y.C. Patel Somatostatin and its receptor family Front. Neuroendocrinol. 20 1999 157 198
99. Y.C. Patel M.T. Greenwood R. Panetta L. Demchyshyn H. Niznik C.B. Srikant The somatostatin receptor family Life Sci. 57 1995 1249 1265
100. M. Pfeiffer T. Koch H. Schroder M. Klutzny S. Kirscht H.J. Kreienkamp V. Hollt S. Schulz Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A) J. Biol. Chem. 2767 2001 14027 14036
101. M. Pilichowska N. Kimura M. Schindler M. Kobari Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas Endocr. Pathol. 12 2001 147 155
102. A. Plonowski A.V. Schally A. Nagy B. Sun K. Szepeshazi Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238 Cancer Res. 59 1999 1947 1953
103. C.Z. Qiu C. Wang Z.X. Huang S.Z. Zhu Y.Y. Wu J.L. Qiu Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67 Bcl-2 and p53 in colorectal cancer World J. Gastroenterol. 12 2006 2011 2015
104. K. Raynor T. Reisine Somatostatin receptors Crit. Rev. Neurobiol. 6 1992 273 289
105. K. Raynor I. Lucki T. Reisine Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats J. Pharmacol. Exp. Ther. 265 1993 67 73
106. K. Raynor W.A. Murphy D.H. Coy J.E. Taylor J.P. Moreau K. Yasuda G.I. Bell T. Reisine Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides Mol. Pharmacol. 43 1993 838 844
107. S. Reichlin Neuroendocrinology J.D. Wilson Williams Textbook of Endocrinology ninth ed. 1998 WB Saunders Philadelphia 165 248
108. T. Reisine G.I. Bell Molecular biology of somatostatin receptors Endocr. Rev. 16 1995 427 442
109. I. Reisinger K.H. Bohuslavitzki W. Brenner S. Braune I. Dittrich A. Geide B. Kettner H.J. Otto S. Schmidt D.L. Munz Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study J. Nucl. Med. 39 1998 224 227
110. J.C. Reubi Somatostatin and other Peptide receptors as tools for tumour diagnosis and treatment Neuroendocrinology 80 S1 2004 51 56
111. J.C. Reubi W. Lang R. Maurer J.W. Koper S.W. Lamberts Distribution and biochemical characterization of somatostatin receptors in tumours of the human central nervous system Cancer Res. 47 1987 5758 5764
112. J.C. Reubi J.A. Chayvialle B. Franc R. Cohen C. Calmettes E. Modigliani Somatostatin receptors and somatostatin content in medullary thyroid carcinomas Lab. Invest. 64 1991 567 573
113. J.C. Reubi J. Laissue E. Krenning S.W. Lamberts Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications J. Steroid. Biochem. Mol. Biol. 43 1992 27 35
114. J.C. Reubi E. Krenning S.W. Lamberts L. Kvols In vitro detection of somatostatin receptors in human tumours Metabolism 41 1992 104 110
115. J.C. Reubi J. Laissue B. Waser U. Horisberger J.C. Schaer Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues Ann. N. Y. Acad. Sci. 733 1994 122 137
116. J.C. Reubi J.C. Schaer B. Waser G. Mengod Expression and localization of somatostatin receptor sst1, sst2, and sst3 messenger RNAs in primary human tumours using in situ hybridization Cancer Res. 54 1994 3455 3459
117. J.C. Reubi B. Waser J.C. Schaer R. Markwalder Somatostatin receptors in human prostate and prostate cancer J. Clin. Endocrinol. Metab. 80 1995 2806 2814
118. J.C. Reubi J.C. Schaer J.A. Laissue B. Waser Somatostatin receptors and their subtypes in human tumours and in peritumoural vessels Metabolism 45 1996 39 41
119. J.C. Reubi J.C. Schaer R. Markwalder B. Waser U. Horisberger J. Laissue Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance Yale J. Biol. Med. 70 1997 471 479
120. J.C. Reubi A. Kappeler B. Waser J. Laissue R.W. Hipkin A. Schonbrunn Immunohistochemical localization of somatostatin receptors sst2A in human tumours Am. J. Pathol. 153 1998 233 245
121. J.C. Reubi J.C. Schaer B. Waser S. Wenger A. Heppeler J.S. Schmitt H.R. Macke Affinity profiles for human somatostatin receptor subtypes sst1-sst5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use Eur. J. Nucl. Med. 27 2000 273 282
122. J.C. Reubi B. Waser Q. Liu J.A. Laissue A. Schonbrunn Subcellular distribution of somatostatin sst2A receptors in human tumours of the nervous and neuroendocrine systems: membranous versus intracellular location J. Clin. Endocrinol. Metab. 85 2000 3882 3891
123. C. Reubi M. Gugger B. Waser Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting Eur. J. Nucl. Med. Mol. Imag. 29 2002 855 862
124. J.C. Reubi H.R. Macke E.P. Krenning Candidates for peptide receptor radiotherapy today and in the future J. Nucl. Med. 46 S1 2005 67S 75S
125. N. Robas E. Mead M. Fidock MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion J. Biol. Chem. 278 2003 44400 44404
126. M. Rocheville D.C. Lange U. Kumar R. Sasi R.C. Patel Y.C. Patel Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers J. Biol. Chem. 275 2000 7862 7869
127. H. Rubinfeld M. Hadani G. Barkai J.E. Taylor M.D. Culler I. Shimon Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas J. Clin. Endocrinol. Metab. 91 2006 2257 2263
128. A. Saveanu G. Gunz S. Guillen H. Dufour M.D. Culler P. Jaquet Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas Neuroendocrinology 83 2006 258 263
129. A. Schonbrunn H. Tashjian Jr. Characterization of functional receptors for somatostatin in rat pituitary cells in culture J. Biol. Chem. 253 1978 6473 6483
130. R. Sestini C. Orlando A. Peri C. Tricarico M. Pazzagli M. Serio A. Pagani G. Bussolati S. Granchi M. Maggi Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumours using competitive reverse transcription-polymerase chain reaction Clin. Cancer Res. 2 1996 1757 1765
131. V. Sibilia G. Muccioli R. Deghenghi F. Pagani V. De Luca D. Rapetti V. Locatelli C. Netti Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat J. Neuroendocrinol. 18 2006 122 128
132. 10-cortistatin-14 labels all five somatostatin receptors Naunyn Schmiedebergs Arch. Pharmacol. 357 1998 483 489
133. M.C. Smith J. Liu T. Chen H. Schran C.M. Yeh F. Jamar R. Valkema W. Bakker L. Kvols E. Krenning S. Pauwels OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy Digestion 62 2000 69 72
134. J. Soga Y. Yakuwa Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas J. Exp. Clin. Cancer Res. 18 1999 13 22
135. A.D. Spier L. de Lecea Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions Brain Res. Brain Res. Rev. 33 2000 228 241
136. A.D. Spier V. Fabre L. de Lecea Cortistatin radioligand binding in wild-type and somatostatin receptor-deficient mouse brain Regul. Pept. 124 2005 179 186
137. C.B. Srikant S. Heisler Relationship between receptor binding and biopotency of somatostatin-14 and somatostatin-28 in mouse pituitary tumour cells Endocrinology 117 1985 271 278
138. G.F. Taboada R.M. Luque W. Bastos R.F. Guimaraes J.B. Marcondes L.M. Chimelli R. Fontes P.J. Mata P.N. Filho D.P. Carvalho R.D. Kineman M.R. Gadelha Quantitative analysis of somatostatin receptor subtype (sst1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas Eur. J. Endocrinol. 156 2007 65 74
139. D. Tamiolakis C. Simopoulos J. Venizelos M. Lambropoulou S. Nikolaidou P. Tsikouras G. Koutsougeras G. Alexiadis M. Menegaki N. Papadopoulos Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: an immunohistochemical analysis Clin. Exp. Med. 5 2005 106 111
140. B. Ueberberg H. Tourne A. Redman M.K. Walz K.W. Schmid K. Mann S. Petersenn Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumours and normal adrenal gland Horm. Metab. Res. 37 2005 722 728
141. I.G. Vainas Octreotide in the management of hormone-refractory prostate cancer Chemotherapy 47 2001 109 126
142. F. Vernejoul P. Faure N. Benali D. Calise G. Tiraby L. Pradayrol C. Susini L. Buscail Antitumour effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models Cancer Res. 6 2002 6124 6131
143. S. Vikic-Topic K.P. Raisch L.K. Kvols S. Vuk-Pavlovic Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumour, and renal cell carcinoma J. Clin. Endocrinol. Metab. 80 1995 2974 2979
144. M. Volante E. Allia P. Gugliotta A. Funaro F. Broglio R. Deghenghi G. Muccioli E. Ghigo M. Papotti Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumours J. Clin. Endocrinol. Metab. 87 2002 1300 1308
145. M. Volante F. Bozzalla-Cassione M. Papotti Somatostatin receptors and their interest in diagnostic pathology Endocr. Pathol. 15 2004 275 291
146. C.H. Wang C.W. Tang C.L. Liu L.P. Tang Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway World J. Gastroenterol. 9 2003 1904 1908
147. C.J. Weber T.M. O’Dorisio B. Howe V. D’Agati L. Ward J. Russell C.R. Feind Vasoactive intestinal polypeptide-, neurotensin-, substance P-, gastrin-releasingpeptide-, calcitonin-, calcitonin gene related peptide-, and somatostatin-like immunoreactivities in human parathyroid glands Surgery 110 1991 1078 1085
148. G.C. Weir S. Bonner-Weir Pancreatic somatostatin Adv. Exp. Med. Biol. 188 1985 403 423
149. M.C. Zatelli D. Piccin F. Tagliati A. Bottoni A. Luchin C. Vignali A. Margutti M. Bondanelli G.C. Pansini M.R. Pelizzo M.D. Culler E.C. Degli Uberti Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives J. Clin. Endocrinol. Metab. 91 2006 2218 2224
150. M.C. Zatelli D. Piccin C. Vignali F. Tagliati M.R. Ambrosio M. Bondanelli V. Cimino A. Bianchi H.A. Schmid M. Scanarini A. Pontecorvi L. De Marinis G. Maira E.C. degli Uberti Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion Endocr. Relat. Cancer 14 2007 91 102
151. C.Y. Zhang Y. Yokogoshi K. Yoshimoto Y. Fujinaka K. Matsumoto S. Saito Point mutation of the somatostatin receptor 2 gene in the human small cell lung cancer cell line COR-L103 Biochem. Biophys. Res. Commun. 210 1995 805 815
152. B. Zhao H. Zhao N. Zhao X.G. Zhu Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment J. Hepatobiliary Pancreat. Surg. 9 2002 497 502